Compare
Airsculpt Technologies, Inc. vs SBC Medical Group Holdings Inc vs Cardiff Lexington Corp
| Latest fiscal year | Airsculpt Technologies, Inc. AIRS | SBC Medical Group Holdings Inc SBC | Cardiff Lexington Corp CDIX |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $151.82M | $173.61M | $11.54M |
| Revenue growth (YoY) | -15.8% | -15.5% | +39.5% |
| Gross margin | n/a | 73.3% | 62.5% |
| Operating margin | -7.6% | 38.9% | 9.5% |
| Net margin | -7.7% | 29.4% | -47.7% |
| Net income | -$11.67M | $50.99M | -$5.51M |
| EPS (Diluted) | -$0.19 | $0.50 | n/a |
| Operating cash flow | $3.10M | $24.67M | -$2.85M |
| Free cash flow | $692.0K | $23.27M | n/a |
| Cash & equivalents | $8.45M | $163.77M | n/a |
| Total assets | $187.30M | $380.45M | $29.09M |
| Total liabilities | $99.59M | $117.14M | $26.01M |
| Shareholders' equity | $87.71M | $248.28M | -$2.47M |
| Return on year-end equity | -13.3% | 20.5% | n/a |
| Shares outstanding | 64.46M | 102.58M | 13.70M |
Revenue, most recent five fiscal years
| Fiscal year | Airsculpt Technologies, Inc. | SBC Medical Group Holdings Inc | Cardiff Lexington Corp |
|---|---|---|---|
| Latest | $151.82M Ended 2025-12-31 | $173.61M Ended 2025-12-31 | $11.54M Ended 2025-12-31 |
| 1 year earlier | $180.35M Ended 2024-12-31 | $205.42M Ended 2024-12-31 | $8.27M Ended 2024-12-31 |
| 2 years earlier | $195.92M Ended 2023-12-31 | $193.54M Ended 2023-12-31 | $11.85M Ended 2023-12-31 |
| 3 years earlier | $168.79M Ended 2022-12-31 | n/a | $10.69M Ended 2022-12-31 |
| 4 years earlier | $133.31M Ended 2021-12-31 | n/a | $9.88M Ended 2021-12-31 |